The Effectivity of Combination of Standard Interferon-alpha

被引:0
|
作者
Ozgunes, Nail [1 ]
Sargin, Fatma [1 ]
Yazici, Saadet [1 ]
Ceylan, Nuket [1 ]
Ucisik, Ayse Canan [1 ]
Ergen, Pinar [1 ]
Dogru, Arzu [1 ]
Aydin, Ozlem [1 ]
机构
[1] SB Goztepe Egitim & Arastirma Hastartesi, Infeks Elastaliklan & Klin Mikrobiyol Klin, Istanbul, Turkey
来源
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL | 2006年 / 11卷 / 02期
关键词
Chronic hepatitis C; interferon alpha; pegylated interferon alpha; ribavirin;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was done in order to evaluate the effectivity of combination therapy of standard interferon alpha (IFN-alpha) + ribavirin and pegylated IFN-alpha (PEG-IFN-alpha) + ribavirin in patients with chronic hepatitis C between 2003-2005 years in our clinic. Totally 52 patients were included in the study. In the combination treatment protocols, standard IFN-alpha 2 alpha or 2b plus ribavirin was given in 35 patients (group I) and PEG-IFN-a plus ribavirin in 17 patients (group II). Duration of treatment was 12 months. Rate of biochemical and virological responses at the end of the therapy and sustained response were 66.6%, 78.7%, 57.7% in group I and 71.4%, 85%, 66.7% in group II, respectively In conclusion, treatment protocols was effective in both groups and the rate of biochemical and virologic responses at the end of the therapy and sustained response were higher in group II than group I but the differences between groups were not significant. In according to the results of this study; PEG-IFN should be preferred to standard IFN-alpha.
引用
收藏
页码:61 / 64
页数:4
相关论文
共 50 条
  • [1] High initial dose combination regimen with interferon-alpha and ribavirin in chronic hepatitis C
    Kostev, I
    Ivanova, I
    Atanassova, M
    Atanassova, A
    Glinkova, V
    Gancheva, D
    Shalev, I
    Manevska, B
    Krasnaliev, I
    Tomcheva, S
    HEPATO-GASTROENTEROLOGY, 2003, 50 (50) : 463 - 466
  • [2] The interferon-alpha revival in CML
    Talpaz, Moshe
    Mercer, Jessica
    Hehlmann, Ruediger
    ANNALS OF HEMATOLOGY, 2015, 94 : S195 - S207
  • [3] Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C
    Carmen Sorina Martin
    Luminita Nicoleta Ionescu
    Carmen Gabriela Barbu
    Anca Elena Sirbu
    Ioana Maria Lambrescu
    Ioana Smarandita Lacau
    Doina Ruxandra Dimulescu
    Simona Vasilica Fica
    BMC Endocrine Disorders, 14
  • [4] In vitro immunomodulatory properties of gemcitabine alone and in combination with interferon-alpha
    Fritz, Jasmin
    Karakhanova, Svetlana
    Brecht, Ramona
    Nachtigall, Ines
    Werner, Jens
    Bazhin, Alexandr V.
    IMMUNOLOGY LETTERS, 2015, 168 (01) : 111 - 119
  • [5] Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C
    Martin, Carmen Sorina
    Ionescu, Luminita Nicoleta
    Barbu, Carmen Gabriela
    Sirbu, Anca Elena
    Lambrescu, Ioana Maria
    Lacau, Ioana Smarandita
    Dimulescu, Doina Ruxandra
    Fica, Simona Vasilica
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [6] NEUROTOXICITY OF INTERFERON-ALPHA
    MERIMSKY, O
    CHAITCHIK, S
    ANTI-CANCER DRUGS, 1992, 3 (06) : 567 - 570
  • [7] Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha
    Barbaro, G
    Di Lorenzo, G
    Soldini, M
    Giancaspro, G
    Pellicelli, A
    Grisorio, B
    Babarini, G
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 (09) : 928 - 933
  • [8] Interferon-alpha for neurofibromas
    Kebudi, R
    Ayan, I
    MEDICAL AND PEDIATRIC ONCOLOGY, 1996, 26 (03): : 220 - 222
  • [9] Combination of interferon-alpha and hydroxyurea in the treatment of idiopathic hypereosinophilic syndrome - Reply
    Malbrain, MLNG
    Zachee, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (04) : 929 - 930
  • [10] Synergistic effects of interferon-alpha in combination with chemoradiation on human pancreatic adenocarcinoma
    Ma, Jian-Hua
    Patrut, Emilia
    Schmidt, Jan
    Knaebel, Hanns-Peter
    Buechler, Markus W.
    Maerten, Angela
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (10) : 1521 - 1528